Furthermore, IL-6 levels were significantly decreased in subjects with dyslipidemia (SMD = -0.34; 95% CI: -0.59, -0.10; <i>P</i> = 0.006; <i>I</i> <sup>2</sup> = 0%). This evidence concerns the gene IL6 and metabolic syndrome.